A detailed history of Northern Trust Corp transactions in Nuvectis Pharma, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 49,827 shares of NVCT stock, worth $363,737. This represents 0.0% of its overall portfolio holdings.

Number of Shares
49,827
Previous 62,097 19.76%
Holding current value
$363,737
Previous $509,000 38.11%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$5.98 - $8.25 $73,374 - $101,227
-12,270 Reduced 19.76%
49,827 $315,000
Q1 2024

May 14, 2024

BUY
$6.69 - $11.0 $3,498 - $5,753
523 Added 0.85%
62,097 $509,000
Q4 2023

Feb 13, 2024

BUY
$7.85 - $11.78 $54,062 - $81,128
6,887 Added 12.59%
61,574 $513,000
Q3 2023

Nov 13, 2023

BUY
$12.89 - $16.29 $13,573 - $17,153
1,053 Added 1.96%
54,687 $704,000
Q2 2023

Aug 11, 2023

BUY
$12.62 - $18.4 $676,861 - $986,865
53,634 New
53,634 $856,000

Others Institutions Holding NVCT

About Nuvectis Pharma, Inc.


  • Ticker NVCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,642,500
  • Market Cap $107M
  • Description
  • Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...
More about NVCT
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.